Why AzurRx BioPharma, Inc. (AZRX) stock is soaring today?
AzurRx BioPharma, Inc. (AZRX) stock was soaring today after the CEO of AzurRx issued a letter to shareholders regarding the acquisition of First Wave Bio. AZRX stock price saw a surge of 9.27%% to reach $4.48 a share at the time of this writing. The trading volume as of now was 6.415,154, very much high as compared to 417,352 average volume. AzurRx BioPharma, Inc is the clinical-stage biopharmaceutical stock that develops recombinant proteins in order to treat gastrointestinal diseases. Its lead product candidate is MS1819 that treats exocrine pancreatic insufficiency. Let’s deep dive to explore more of it. AZRX stock